Steve Jensen Joins The Weinberg Group (now ProPharma Group)

February 3, 2015

The Weinberg Group (now ProPharma Group), the leading FDA consulting firm, is pleased to announce that Steve Jensen has joined us as Senior Vice President, Head of Regulatory Consulting. Steve has over 20 years of industry experience including executive roles at Iroko, Verus and SkyePharma. He has had responsibility for products under development and launch, including managing multiple FDA submissions and meetings.
"Steve is a welcome addition to our team," said Matthew Weinberg, CEO. "His ability to synthesize a deep regulatory background in tandem with scientific expertise is the essence of what we do. His addition will strengthen the best team in the industry. We look forward to the leadership and guidance Steve will provide."
Steve Jensen

Senior Vice President, Head of Regulatory Consulting

+1 706.286.8841 direct

+1 706.371.8206 mobile

TAGS:

April 24, 2018

ProPharma Group Announces New President / CEO

ProPharma Group announced today that Dawn Sherman has been named President and CEO, effective May 14, 2018. A veteran in leading healthcare-focused businesses, Dawn brings extensive international...

January 28, 2019

ProPharma Group Acquires The Weinberg Group

ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and...

New ProPharma office building in Overland Park, Kansas City

August 31, 2013

Featured News for ProPharma Group Kansas Office

Due in large part to the continued support from our loyal clients, ProPharma Group has officially outgrown our existing Kansas location and has relocated to a larger office in Overland Park, Kansas!...